This study showed that FXR is a transcriptional activator that directly binds to the DR2 element (−338 to −325) in the miR-122 promoter region, thereby suppressing the proliferation of HCC cells and the growth of HCC xenografts in vivo [205]. This evidence concerns the gene NR1H4 and hepatocellular carcinoma.